GP
CME icon

Geneva Partners’s CME Group CME Stock Holding History

Geneva Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,520
Closed -$954K – 81
2020
Q1 		$954K Sell
5,520
-1,521
-22% -$303K 1.36% 27
2019
Q4 		$1.41M Sell
7,041
-9,762
-58% -$2M 0.97% 37
2019
Q3 		$3.55M Buy
+16,803
New +$3.51M 2.76% 14

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geneva Partners's CME Position: Q2 2020 in Review

Geneva Partners sold out of CME Group (CME) in Q2 2020, closing a stake of 5,520 shares — an estimated $954K sold.

Geneva Partners first reported a position in CME in Q3 2019 and held it in 3 quarters. The position peaked at $3.55M in Q3 2019. 1,046 funds tracked by Wall St. Rank hold CME as of Q2 2020.

  • Geneva Partners reported no remaining CME Group position as of Q2 2020 after selling out during the quarter.
  • Geneva Partners sold 5,520 CME Group shares in Q2 2020, an estimated $954K.
  • Geneva Partners first reported a position in CME Group in Q3 2019 and held it in 3 quarters.
  • Geneva Partners's CME Group position peaked at $3.55M in Q3 2019.
  • 1,046 funds tracked by Wall St. Rank held CME Group as of Q2 2020.

Based on Geneva Partners's 13F filing for Q2 2020, filed 20 Jul 2020.